Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of "Hold" by Analysts
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have earned an average recommendation of "Hold" from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given...